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We tested the hypothesis that cross-bridge mechanisms of contraction differed in early
postmenopausal women who did or did not receive hormone replacement therapy (HRT). Vastus
lateralis biopsies were obtained from 17 postmenopausal women (49–57 years old), 8 of whom
were on HRT for the previous 24 6 5 months and 9 of whom were never on HRT.
Electrophoresis and enzyme histochemistry revealed that fiber myosin heavy chain (MHC)
isoform distribution, the cross-sectional area (CSA) of slow and fast fibers, and the relative CSA
occupied by each, were similar for HRT and non-HRT groups. Single permeabilized fibers
containing type IIa MHC had greater Ca21-activated peak specific force, unloaded shortening
velocity, and peak power than fibers containing type I MHC, but in all cases the values for HRT
and non-HRT groups were similar. In this cross-sectional study, we found no evidence that Ca21activated fiber function, MHC isoform distribution, or relative CSA occupied by slow and fast
fibers differed between HRT and non-HRT groups.

UMAN muscular strength peaks during the third
H
decade of life, remains relatively stable over the next
three decades, and then begins to decline, falling to 60–70%
of its peak level by the seventh to eighth decades of life
(1,2). This decline in voluntary strength has important
health-related consequences, ranging from the inability to
perform activities of daily living, such as rising from a chair
(3), to an increased risk for falling (4). The main peripheral
contributors to these age-related losses in neuromuscular
function are muscle atrophy and a reduction in the intrinsic
ability of muscles to produce force (1,5,6). The latter is
a consequence of impaired excitation–contraction coupling,
and alterations in cross-bridge mechanisms of contraction
(7–10).
Data from cross-sectional studies suggest that the agerelated decline in voluntary strength occurs at an earlier age
in women than in men (11,12). For instance, beginning
in the 45- to 55-year-old age group, the specific strength
(strength–muscle cross-sectional area) of the adductor
pollicis was found to be substantially lower for female
subjects than for male subjects (11). Further analysis of this
age group revealed that the force deficit was confined to
those women not on hormone replacement therapy (HRT),
because women on HRT had strength comparable with their
male counterparts. These observations lead to the hypothesis
that a causal relationship exists between estrogen and
muscular performance in postmenopausal women (11).
This hypothesis is supported by the finding that HRT
treatments prevent an age-related reduction in knee extensor
strength (13) and improve knee extensor and adductor

pollicus strength of postmenopausal women (14,15).
Nevertheless, the hypothesis remains controversial, because
several other longitudinal studies have found little support
for the role of HRT in maintaining or improving handgrip
strength, knee extensor strength, or leg extension power in
postmenopausal women (16,17).
Previous HRT studies have evaluated muscle performance by assessing maximal voluntary contractions. Muscle
performance measured under these conditions is a function
of central (neural) and peripheral (muscular) factors. In an
extensive review of the literature, Gandevia (18) concluded
that ‘‘no muscle appears blessed with truly optimal drive
during maximal isometric efforts.’’ To our knowledge,
only one HRT study has directly addressed this issue of
incomplete muscle activation (13), although other studies
have assumed maximal activation (11,14) on the basis of
results from their previous research (19).
Physiological cross-sectional area (CSA), fiber type
composition, and the contractile properties of individual
muscle fibers all contribute to the peripheral or mechanical
properties of a muscle. In this context, it is noteworthy that
the studies showing the greatest effects of HRT are those
that have examined the function of the adductor pollicis
(11,14), whereas those showing relatively small but statistically significant benefits with HRT (13,15), or no benefits at all (16,17), have been conducted on the knee
extensors. The adductor pollicis has a relatively consistent
fiber type composition (20) with a generally parallel fiber
architecture (19). This latter characteristic means that the
anatomical CSA of the muscle, which can be reliably
3
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measured (19), is equivalent to its physiological CSA. In
contrast, the muscles comprising the knee extensors
generally have a mixed fiber type composition (21) and
have a complex pennate architecture (22). This latter feature
makes it difficult to properly normalize force measurements
between subjects.
Our working hypothesis is that discrepancies between
previous HRT studies may be attributed to the difficulty
in normalizing or interpreting measurements of voluntary
strength. Therefore, in this study we have taken an alternative approach to evaluate muscle function. Using
adenosine triphosphatase (ATPase) histochemistry, singlefiber gel electrophoresis, and an in vitro single-cell
functional preparation, we have assessed the CSA, fiber
type distribution, and Ca21-activated contractile properties
of muscle fibers obtained from two groups of early
postmenopausal women: those on HRT since menopause
and those never receiving HRT. This approach eliminates
many of the uncertainties associated with measurements of
voluntary neuromuscular strength. This methodology also
allows us to test the hypothesis put forward by Phillips and
coworkers (11) that the site of action of HRT is at the level
of the actomyosin cross bridges.
METHODS
Subjects

Seventeen healthy, postmenopausal women volunteered
to participate in this study. These individuals were a subset
of subjects participating in a larger, longitudinal study that
examined bone mineral density after menopause. Subjects
were selected from a pool of volunteers who responded to
newspaper advertisements or who had been referred to the
study by their physicians. The study was approved by the
Institutional Review Board at Oregon State University. All
subjects provided written consent after being fully informed
of the nature of the study.
Follicle-stimulating hormone levels were >20 mIU/ml
for all subjects (confirmed by each subject’s physician).
Nine of the women had never taken HRT (non-HRT group:
22 6 6 months since being diagnosed as postmenopausal).
The other 8 subjects had been taking HRT since, or shortly
before, they were diagnosed as postmenopausal (HRT
group: 20 6 3 months since being diagnosed as postmenopausal; 24 6 5 months on HRT). HRT consisted of
conjugated estrogens (0.625 mg/d).
Body Composition

Body composition was determined by dual-energy x-ray
absorbtiometry (QDR-4500 Elite A, Hologic, Inc., Waltham,
MA) as previously described (23). Scans were analyzed
by using Hologic software version 9.80 D (Hologic).
Voluntary Knee Extension Strength

Peak torque of the left knee extensors was evaluated by
isokinetic dynamometry (KIN-COM 500H, Chattex Corp.,
Hixson, TN). All tests were conducted at a speed of 30
degrees per second and were gravity corrected. After
a demonstration of procedures, each subject was positioned

to isolate the muscle group being tested and instructed to
perform 10–12 trials at an intensity well below maximum.
After this warm-up, subjects performed between three and
five maximal efforts in order to determine peak force and
torque. Each maximal effort was separated by approximately 60 seconds of rest.
Physical Activity

Current physical activity levels were assessed by using
a questionnaire administered during a laboratory visit (24).
The questionnaire asked subjects to recall the duration and
intensity of their typical weekly recreational, leisure, and
household activities for the 6 months leading up to the
study.
Muscle Biopsy

A muscle sample of the left vastus lateralis was obtained
by using the percutaneous needle biopsy technique. One
portion of the sample was immediately placed in cold
dissection solution (for composition, see the paragraphs that
follow), where it was divided into small bundles of fibers
for use in the functional experiments. These bundles were
stored in skinning solution (composition is given in a later
subsection) at 48C for 24 hours before they were transferred
to fresh skinning solution and stored at 2208C for up to 3
weeks. Another portion of the biopsy sample was aligned
vertically in tissue mounting medium and frozen in isopentane that was cooled to its freezing point with liquid nitrogen. This sample was stored in an airtight cryotube at 2808C
for later histochemical analysis.
Enzyme Histochemistry and Morphology

The muscle samples were sectioned on a cryostat
(model CM1800; Leica Microsystems, Nussloch, Germany)
at 2208C. Sections that were 8–10 lm thick were picked
up on cover slips, air dried, and stained for myofibrillar
ATPase. Sections were stained at pH 9.4 after both alkaline
(pH 10) and two different acid (pH 4.35 and 4.65) preincubations. Stained sections were mounted on glass slides
and photos of the sections were taken at 1003. Photographs
were converted into digital files with a flatbed scanner.
Image analysis software (Scion Image, Scion Corp.,
Frederick, MD) was used to determine the CSA of fibers
that were free of artifacts, had distinct cell borders, and had
no tendency toward a longitudinal cut.
Functional Studies

The composition of the solutions used for the functional
studies was determined by an iterative computer program
(25) using stability constants adjusted for ionic strength,
pH, and temperature (26). All solutions contained 7.0mM
EGTA [ethylene glycol-bis(2-aminoethyl)-N,N,N9,N9-tetraacetic acid], 20.0mM imidazole, 1mM free Mg21, 4mM
ATP (adenosine-59-triphosphate), 14.5mM creatine phosphate, and 15 U ml21 creatine kinase. The free Ca21
concentration of the relaxing and activating solutions was
adjusted to pCa 9.0 and pCa 4.5, where pCa is 2log[Ca21],
respectively, with a 100mM CaCl2 standard solution
(Calcium Molarity Standard, Corning Inc., Corning, NY).
In both solutions, pH was adjusted to 7.0 by using KOH
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(potassium hydroxide), and sufficient KCl (potassium
chloride) was added to bring the total ionic strength to
180mM.
The dissection solution consisted of relaxing solution and
a protease inhibitor cocktail prepared according to the
manufacturer (Complete Mini EDTA-Free Protease Inhibitor Tablets, Boehringer Mannheim, Indianapolis, IN).
The skinning solution was made by mixing equal volumes
of dissection solution and glycerol.
On the day of an experiment, a muscle bundle was
transferred from skinning to relaxing solution. Muscle fiber
segments were isolated by holding one corner of the bundle
with forceps and inserting fine forceps (Dumont #5) into the
opposite end of the bundle in order to grasp and gently
remove a fiber segment. The single fiber segment was
mounted between an isometric force transducer (Model 400,
Aurora Scientific, Aurora, Ontario) and a servo-controlled
motor (Model 308B, Aurora Scientific) as previously
described (27). Outputs from the transducer and motor
were amplified before being digitized (5 kHz) and interfaced
to a personal computer by means of a data-acquisition board
(Model AT-MIO-16E, National Instruments, Austin, TX).
Data collection and analysis were carried out by using
a computer program written in our laboratory (LabView,
National Instruments, Austin, TX).
The mounted fiber was suspended in one of several glassbottomed chambers milled into a stainless-steel dip plate.
Depression and translation of the plate enabled the investigator to rapidly move the fiber segment from chamber
to chamber. The plate was mounted on an inverted microscope (Olympus IX-70, Olympus America Inc., Melville,
NY), where sarcomere length was adjusted to 2.5 lm
(measured by a calibrated eyepiece micrometer) by using
three-axis micromanipulators attached to the transducer
and motor. Fiber length (FL) was measured by translating
the fiber across the microscope’s field of view, using
a digital micrometer attached to the mechanical stage of the
microscope. Fiber CSA was determined by measuring the
fiber width while the mounted fiber was briefly suspended
in air (,5 seconds) and calculating the CSA by assuming
that the fiber forms a cylinder in air (27,28). Three CSA
measurements were made along the length of the fiber
(with the fiber returned to the relaxing solution between
measurements) and the mean was taken as fiber CSA.
Temperature was monitored by a thermocouple that was
inserted into the solution bathing the fiber. Solution
temperature was maintained at 158C throughout the
experiments.
Unloaded shortening velocity (Vo) was determined by
using the slack test method (Figure 1A). Fibers were also
subjected to a series of isotonic contractions in order to
construct force–velocity–power relationships (Figure 1B).
For both slack tests and isotonic contractions, total
shortening never exceeded 20% of FL. Peak Ca21-activated
force was determined as the difference in the maximum
force produced during Ca21 activation and the force
baseline attained while the fiber was slack. Following the
physiological measurements, the fiber was removed from
the instruments, dissolved in 30 ll of sodium dodecyl
sulfate (SDS) sample buffer, and stored at 2808C.

5

Figure 1. Examples of the slack test (A) and force–velocity test (B)
methodology. A, The inset illustrates a force record obtained during a single
slack step. Note that the slack step caused force to drop to baseline. The fiber
shortened under no load until there was a rapid redevelopment of force
(horizontal calibration bar, 100 ms; vertical calibration bar, 0.20 mN). In the
main panel, the duration of unloaded shortening has been plotted against the
slack step distance for this contraction ( ) along with four other slack steps (*).
The plot was fit by a least-squares regression line (R2 5 .998). The slope of the
relationship, normalized to FL, defines Vo (0.65 FL/s). Later, gel electorphoresis
indicated that the fiber in this example contained the type I MHC isoform. B,
The insert illustrates one series of three isotonic contractions. After the fiber
attained peak force, the servomotor subjected the fiber to three periods of
isotonic shortening, followed by a slack step to zero the force transducer. The
position record shows corresponding changes in motor position. Force and
shortening velocity (slope of the position record) were measured over the second
half of each step (horizontal calibration bars, 100 ms; vertical calibration bars,
100 lm and 0.20 mN). In the main panel, data from this contraction cycle
( ) and two other cycles (*) have been plotted and fit (R2 5 .998) by the
Hill equation (44). Parameters describing this particular relationship were Vmax
5 2.22 FL/s, a/Po 5 0.033, and Po 5 0.68 mN (157 kN/m2). The force–power
relationship illustrated in the figure was calculated from these parameters (45).
Gel electrophoresis indicated that this fiber contained type IIa MHC isoform.
FL 5 fiber length; MHC 5 myosin heavy chain.

Determination of Fiber Myosin Heavy Chain
Isoform Content

Gel electrophoresis was used to determine the myosin
heavy chain (MHC) isoform content of all of the fibers
subjected to functional assessment. In addition, ;50
additional fiber segments per subject were isolated from
the skinned muscle bundles (using the same technique
described herein for the functional experiments) and stored
in SDS buffer for MHC isoform analysis.
Gel electrophoresis and silver staining were carried out
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height (167 6 3 and 165 6 3 cm), total body mass (66.3
6 3.8 and 67.4 6 5.3 kg), and lean body mass (44.7 6
1.9 and 43.6 6 2.6 kg). The non-HRT and HRT groups had
similar levels of physical activity (54 6 11 and 43 6 7
MET-h/wk, respectively, where 1 MET is 1 multiple of the
resting metabolic rate). Voluntary knee extension strength
(non-HRT, 163 6 10 N m; HRT, 146 6 11 N m) did not
differ between groups in absolute terms or when adjusted
for individual lean body mass or left leg lean mass (analysis
of covariance).
Histochemistry

An example of a muscle cross section, stained for
myofibrillar ATPase, is illustrated in Figure 2A. Three distinct fiber types could be distinguished on some, but not all,
sections. Therefore, fibers were classified as type I or II on
the basis of their histochemical staining characteristics, and
no attempt was made to subclassify the type II fibers. We
were unable to analyze samples from 2 subjects (both from
the HRT group) because of an insufficient number of fibers
that were free of artifact.
On average, 38% of the fibers were classified as type I,
and these fibers were significantly larger in CSA than the
type II fibers (Table 1). However, despite their smaller fiber
CSA, the greater relative occurrence of fast fibers meant that
a significantly greater percentage of the total sample area
was composed of this fiber type. These relationships for
fiber type distribution, fiber CSA, and relative fiber CSA
were all independent of HRT status.

Figure 2. Examples of enzyme histochemistry and gel electrophoresis. A,
Photograph of muscle section stained for myofibrillar adenosine triphosphatase
at pH 10.0. Type I fibers are light in color; type II fibers are dark. B, Portion of
a polyacrylamide gel used to determine fiber myosin heavy chain isoform
content. Lane A was loaded with a human myosin standard. Note the separation
of the three myosin heavy chain isoforms present in human skeletal muscle.
Fiber segments from three separate experiments were run in lanes B, C, and D.

as previously described (27). A human myosin standard,
prepared from an extract of human vastus lateralis muscle, was
run on one or more lanes of each gel. This standard was used to
identify the isoform(s) present in each fiber segment, using the
order of migration of human adult MHC isoforms (29).
Statistical Analysis

Fiber MHC Content

Descriptive characteristics of the two groups were
compared by using a one-way analysis of variance
(ANOVA). An analysis of covariance was used to compare
knee extension strength while left leg lean mass and total
body lean mass were controlled for. The histochemical and
single-fiber MHC isoform data were analyzed with a twoway ANOVA (main effects of HRT treatment and fiber
type). Fiber functional data were analyzed by using an
ANOVA (main effects of MHC isoform content and HRT
treatment with subjects nested within hormone treatment).
Statistical significance was accepted at p , .05. All data are
presented as mean 6 SE.

A total of 1110 single fibers were subjected to gel
electrophoresis. A gel illustrating MHC isoform identification in single-fiber segments is presented in Figure 2B.
There were no intergroup differences in the relative number
of fibers expressing each particular MHC isoform or
combinations of isoforms (Table 2). On average, 46 6 1%,
35 6 1%, and 5 6 1% of the fibers expressed type I, IIa, or
IIx MHC, respectively. The remaining fibers expressed
various combinations of isoforms, including types I and
IIa (5 6 1%) and types IIa and IIx (8 6 1%).
Functional Properties of Single Fibers

Approximately 90% of the fibers isolated for functional
analysis contained either type I or IIa MHC. The average
CSA, absolute force (millinewtons), and specific force
(force per fiber CSA, in kilonewtons per square meter) of
these fibers are presented in Table 3. Fibers expressing type

RESULTS
Characteristics of the Subjects

The 9 non-HRT and 8 HRT subjects were similar (p . .05)
in age (52.9 6 0.8 and 52.3 6 0.7 years, respectively),

Table 1. Histochemical Analysis of Muscle Biopsy Samples From HRT and Non-HRT Groups
Fiber Area (lm2)

Fiber Type (%)

Fiber Area (% Total Area)

Group

Type I

Type II

Type I

Type II

Non-HRT
HRT
Mean

38 6 3
38 6 3
38 6 2

62 6 3
62 6 3
62 6 2*

3560 6 222
3603 6 396
3577 6 198

2648 6 174
2850 6 309
2729 6 157*

Type I
45 6 3
43 6 3
44 6 2

Type II
55 6 3
57 6 3
56 6 2*

Notes: Non-HRT 5 postmenopausal women not receiving hormone replacement therapy; HRT 5 postmenopausal women receiving hormone replacement
therapy. Values are means 6 SE for 9 non-HRT and 6 HRT subjects. An average of 106 6 fibers were analyzed per subject.
*This indicates a significant difference from type I fibers (p , .05).
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Table 2. MHC Isoform Content of Vastus Lateralis Muscle Fibers
From HRT and Non-HRT Groups
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Table 3. CSA and Peak Ca21-Activated Force of Skinned Fiber
Segments From HRT and Non-HRT Groups
MHC Isoform

MHC Isoform
Group
Non-HRT
HRT

I

I/IIa

IIa

IIa/IIx

IIx

I/IIx

I/IIa/IIx

Variable/Group

46 6 4
46 6 4

462
562

35 6 4
35 6 4

862
963

662
361

,1
0

161
261

CSA (lm2)
Non-HRT
HRT
Mean
Peak force (mN)
Non-HRT
HRT
Mean
Specific force (kN/m2)
Non-HRT
HRT
Mean

Notes: MHC 5 myosin heavy chain; non-HRT 5 postmenopausal women
not receiving hormone replacement therapy; HRT 5 postmenopausal women
receiving hormone replacement therapy. Values are average 6 SE percents of
fibers from 9 non-HRT (589 total fibers) and 8 HRT subjects (521 total fibers).

I MHC were significantly larger in CSA than the fibers
expressing the IIa isoform. However, fibers expressing type
IIa MHC produced greater specific force than fibers
containing the type I isoform, and as a result, absolute
peak Ca21-activated force was similar for type I and IIa
fibers. There was no significant HRT effect or HRT by
MHC interaction for any of these variables, indicating that
the relationships among fiber MHC isoform content and
CSA, absolute force, and specific force were similar for the
HRT and non-HRT groups.
There was a significant main effect of MHC isoform
expression on fiber Vo (determined from slack test measurements) with fibers expressing the type IIa isoform
shortening ;4.5-fold faster than fibers containing the type I
isoform (Table 4). This relationship did not differ between
fibers from the non-HRT and the HRT groups. Consistent
with the Vo results, analysis of force–velocity relationships
indicated that fiber Vmax (extrapolated velocity axis intercept of the force–velocity relationship) was significantly
faster in fibers expressing type IIa MHC (non-HRT, 1.98 6
0.11 FL/s, n 5 35; HRT, 1.93 6 0.12 FL/s, n 5 28) than
in fibers expressing type I MHC (non-HRT, 0.69 6 0.02 FL/
s, n 5 48; HRT, 0.69 6 0.04 FL/s, n 5 43). The curvature
of the force–velocity relationship, as indicated by the
parameter a/Po, was also greater for type IIa fibers (nonHRT, 0.047 6 0.003 FL/s; HRT, 0.050 6 0.004 FL/s) than
for type I fibers (non-HRT, 0.027 6 0.001 FL/s; HRT,
0.029 6 0.002 FL/s). However, for both Vmax and a/Po, no
significant differences were observed between fibers
obtained from the non-HRT versus the HRT group for
either fiber type.
Fiber peak power, expressed either in absolute terms
(micronewtons per FL per second) or normalized to fiber
volume (watts/liter), was greater in fibers expressing type IIa
MHC than in those expressing the type I isoform (Table 5).
There were no differences in peak power of either slow or
fast fibers as a result of HRT status.
DISCUSSION
To our knowledge, the present study is the first to
examine cellular properties of muscle fibers from early
postmenopausal women who differ in their HRT status.
Consistent with previous studies conducted on female
subjects, we found that slow and fast vastus lateralis fibers
differed in several characteristic ways. For instance, slow
fibers were, on average, larger in CSA than fast fibers.
However, because slow fibers were less prevalent than fast
fibers, slow fibers occupied less relative CSA of the vastus

I

IIa

5297 6 193 (64)
5005 6 226 (63)
5153 6 148

4150 6 231 (41)
4187 6 232 (36)
4167 6 163*

0.61 6 0.02
0.57 6 0.02
0.59 6 0.02

0.59 6 0.03
0.61 6 0.03
0.60 6 0.02

117 6 2
116 6 2
116 6 2

147 6 4
149 6 3
148 6 3*

Notes: MHC 5 myosin heavy chain; CSA 5 cross-sectional area; nonHRT 5 postmenopausal women receiving no estrogen therapy; HRT 5 postmenopausal women receiving estrogen replacement theory. Values are means
6 SE with number of fibers indicated in parentheses. Fibers were obtained
from 9 non-HRT and 8 HRT subjects.
*This indicates a significant main effect of MHC (p , .05).

lateralis sample than fast fibers. These results are in
agreement with previous studies that have examined vastus
lateralis fibers from younger female subjects (30,31). In
addition, differences in the functional properties of Ca21activated slow and fast fibers, including the lower specific
force, unloaded shortening velocity, and peak power of the
former, are consistent with previous data for young and
middle-aged male (27,32–34) and young female (10,35)
subjects.
The novel finding of this study is that these morphological and functional properties, which were specific to fiber
type, were independent of HRT status. Fiber CSA, fiber type
distribution, relative fiber type CSA, and Ca21-activated
functional properties of slow and fast fibers did not differ
between the early postmenopausal women who received
HRT and those who did not.
Phillips and colleagues (11) have proposed that HRT acts
at the level of the cross bridge to improve skeletal muscle
performance. There are several mechanisms by which HRT
could potentially improve muscle performance under this
hypothesis. First, HRT could increase the number of cross
bridges in parallel by inducing muscle fiber hypertrophy.
This mechanism would be consistent with the results of
Sipilä and coworkers (15), who reported 3% and 7%
increases in quadriceps lean tissue CSA after 6 and 12
months of HRT, respectively. However, using two independent methods of analysis (skinned fibers and enzyme
histochemistry), we found no evidence that slow or fast
muscle fibers from the HRT subjects were larger in CSA
than corresponding fibers from their non-HRT peers.
Alternatively, HRT could improve muscular performance
by altering the quality of the muscle tissue. This mechanism
is consistent with cross-sectional and longitudinal studies
showing greater specific force of the adductor pollicis of
women on HRT (11,14). Because we observed that fast
muscle fibers produced greater specific force than slow
fibers, a shift in fiber type distribution, or a change in the
relative area occupied by either fiber type, might be
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expected to increase the overall specific force of the muscle.
However, fiber type distribution, the relative MHC isoform
content of individual fibers, and the relative area occupied
by either slow or fast fibers did not differ between HRT and
non-HRT groups.
Finally, HRT could affect the specific force of individual
muscle fibers. In support of this mechanism, Wattanapermpool and Reiser (36) found that slow soleus fibers obtained
from young rats, ovariectomized at 8–10 weeks of age
and then studied either 10 or 14 weeks later, produced
significantly less specific force than fibers from shamoperated control animals. However, in the present study, no
intergroup differences were observed in the average specific
force of fibers containing type I or IIa MHC. These fibers
accounted for ;80% of the total fibers isolated from the
biopsy samples (Table 2). Only a few fibers containing
types I/IIa (n 5 5), IIa/IIx (n 5 13), and IIx (n 5 3) were
isolated for functional analysis, and the small sample sizes
preclude statistical analysis. However, assuming these fibers
make up 20% of total fibers (Table 2) and that all other
factors are equal, we find 1.75- to 2-fold intergroup
differences in the specific force of the I/IIa, IIa/IIx, and
IIx fibers would be required to account for the 15–20%
greater muscle specific force previously reported for women
on HRT (11,14). A difference of this magnitude seems
unreasonable, making it unlikely that the greater muscle
specific force of HRT subjects can be attributed to differences in the specific force of individual muscle fibers.
Significant increases in vertical jump height following 6
and 12 months of HRT (15) suggest that HRT may improve
muscle power. We therefore evaluated the ability of Ca21activated fibers to shorten and to produce power. In agreement with previous work (27,33,34), both Vo and peak
power were highly dependent on MHC isoform content.
However, no intergroup differences were observed for
either variable.
The primary finding of this study is the consistency in
fiber type distribution, fiber CSA, and Ca21-activated fiber
function between non-HRT and HRT subjects. Although
these results do not eliminate an influence of HRT on
muscle performance, they do suggest that any potential site
of action is unlikely to be at the level of the cross bridge per
se. This conclusion must be interpreted in light of the
limitations of the present study. Because we used a crosssectional design, individual subject variation in fiber
characteristics may have obscured an effect of HRT.
Although this is certainly a possibility, it is noteworthy that
the specific force, Vo, and peak power–volume of the fibers
obtained from both the HRT and non-HRT groups are in
very good agreement with data obtained from 20- to 30year-old male subjects recently studied in our laboratory
(27). This suggests that the present middle-aged subjects
had not experienced the reductions in muscle fiber specific
force and Vo that have been observed in older populations
(9,10). Although not directly tested, the present data suggest
that cross-bridge mechanisms of contraction are not altered
during the initial years of menopause. If this is the case, then
it is difficult to envision how HRT could augment the
contractility of Ca21-activated fibers that appear to have
normal function.

Table 4. Unloaded Shortening Velocity of Skinned Fiber Segments
From HRT and Non-HRT Groups
MHC Isoform
Group
Non-HRT
HRT
Mean

I

IIa

0.61 6 0.02 (54)
0.58 6 0.01 (53)
0.59 6 0.01

2.80 6 0.12 (39)
2.67 6 0.14 (29)
2.75 6 0.09*

Notes: HRT 5 postmenopausal women receiving hormone replacement
therapy; non-HRT 5 postmenopausal women not receiving hormone replacement therapy; MHC 5 myosin heavy chain. Values are means 6 SE with
number of fibers indicated in parentheses. Fibers were obtained from 9 nonHRT and 8 HRT subjects.
*This indicates a significant main effect of MHC (p , .05).

On the basis of this argument, it is conceivable that the
women in this study were too young to experience an effect
of HRT on muscle fiber morphology or function. Alternatively, the duration of HRT treatment may have been too
brief to induce a treatment effect. However, the age of the
subjects and the duration of HRT treatment are in good
agreement with the studies conducted by Greeves and
coworkers (13) and Sipilä and coworkers (15), both of
which reported beneficial effects of HRT on voluntary knee
extension strength. It could also be argued that because no
intergroup differences in knee extension strength were
observed, our subjects were somehow different than those
examined in these previous studies. However, as detailed at
the beginning of this paper, there are limitations in using
voluntary strength measurements as an index of muscular
function. Because our goal was to investigate cellular mechanisms responsible for muscle contraction, the fact that knee
extension strength did not differ between our groups has
little bearing on our rationale for conducting this study.
Because of the complexity of the intact neuromuscular
system, changes in neuromuscular strength or performance
are not always accompanied by alterations in the functional
properties of single muscle fibers (37). Conversely, muscle
fiber atrophy and contractile dysfunction (38,39), as well as
reductions in electrically stimulated muscle torque (40),
have been observed to occur without corresponding changes
in the voluntary strength of the same subjects (40).
The single-cell experiments described here are labor and
time intensive and must be completed while the fibers
remain viable (within the 3–4 weeks immediately following
the biopsy). This imposes limitations on sample size, and it
is possible that this reduced our ability to detect differences
between groups. We have investigated this possibility by
computing effect size. For all physiological variables in
Tables 3–5, effect sizes related to the HRT treatment were
< 0.007. In contrast, effect size for comparisons based on
MHC isoform content were 0.109, 0.005, and 0.408 for fiber
CSA, absolute force, and specific force, respectively, and
0.854, 0.831, and 0.902 for fiber Vo, absolute power, and
normalized power, respectively. On the basis of Cohen’s
criteria (41), effect sizes of 0.20–0.50 are considered small
differences and those . 0.80 are considered to be large.
Because the effect sizes observed here for the HRT
treatment are negligible, increasing the sample size would
have little influence on meaningful differences between non-
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Table 5. Peak Power of Skinned Fiber Segments From HRT and NonHRT Groups
MHC
Group
Micronewtons per FL per second
Non-HRT
HRT
Mean
Watts/liter
Non-HRT
HRT
Mean

I

IIa

7.73 6 0.42 (48)
7.42 6 0.43 (43)
7.58 6 0.30

33.3 6 1.5 (35)
33.5 6 1.8 (28)
33.4 61.2*

1.50 6 0.05
1.52 6 0.05
1.51 6 0.03

8.21 6 0.36
8.60 6 0.31
8.38 6 0.24*

Notes: HRT 5 postmenopausal women receiving hormone replacement
therapy; non-HRT 5 postmenopausal women not receiving hormone replacement therapy; FL 5 Fiber length; MHC 5 myosin heavy chain. Values are
means 6 SE with number of fibers indicated in parentheses. Fibers were obtained from 9 non-HRT and 8 HRT subjects.
*This indicates a significant main effect of MHC (p , .05).

HRT and HRT groups. Our conclusions regarding the HRT
treatment cannot be easily dismissed as an artifact of sample
size.
In this study, we examined only one aspect of muscle cell
function under very controlled conditions. Because our
preparation bypassed processes involved in normal cell
activation and relaxation, one cannot rule out a potential
effect of HRT on mechanisms of action potential propagation or excitation–contraction coupling. Indeed, faster
relaxation times have been observed in several hindlimb
muscles obtained from ovariectomized rats (42), suggesting
an influence of estrogen on sarcoplasmic reticulum function.
It has been suggested by Phillips and colleagues (11) that
HRT may alter the distribution of low- and high-force cross
bridges by modifying their sensitivity to intracellular
metabolites such as inorganic phosphate (Pi) or hydrogen
ion (H1). Alternatively, HRT could alter the concentrations of these metabolites. Because the concentrations of Pi
and H1 in slow and fast muscle fibers of postmenopausal
women are not known, their potential effects on fiber
contractility could not be tested in the present study. To
reiterate, the present results do not eliminate an influence of
HRT on those aspects of muscle contraction, including both
neural and peripheral mechanisms, that were not examined
in this study.
Finally, we performed histochemistry and functional
measurements on fibers from the same muscle samples,
and we wish to draw attention to two methodological issues
pertinent to this type of dual analysis. The first issue concerns the large differences in fiber CSA one can observe
between our histochemical results and our skinned fiber
analysis. This apparent discrepancy can be attributed to the
20% increase in fiber diameter, or 44% increase in fiber
CSA, that occurs during the chemical skinning process (43).
Once the skinned fiber CSAs are adjusted for this swelling,
the histochemical and skinned fiber results are in good
agreement. Second, a lower percentage of fibers were
classified as type I by enzyme histochemistry compared
with the electrophoretic analysis of fiber MHC isoforms.
Note that the histochemical fiber type analysis is based on
the numerical occurrence of fibers in a sample. In contrast,
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the isolation of fibers used in the MHC isoform analysis
is based on the relative CSA occupied by each particular
type of fiber in the sample (because fibers are isolated by
randomly inserting forceps into the ends of the muscle
bundles). Thus, the single-fiber MHC isoform content
results are in much closer agreement with the histochemical
relative fiber CSA results versus the histochemical fiber type
percentages.
Conclusions

In summary, we found no compelling evidence that fiber
type distribution (on the basis of enzyme histochemistry and
MHC isoform analysis), absolute fiber CSA, relative fiber
CSA (CSA per fiber type), or the Ca21-activated functional
properties (absolute force, specific force, shortening velocity, and peak power) of vastus lateralis muscle fibers
differed between early postmenopausal women who had
received HRT for 2 years versus those who had never
received HRT. These results suggest that the morphological
and functional characteristics examined in this study are
insensitive to HRT during the initial years of menopause.
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Arch. 1981;391:334–337.
44. Hill AV. The heat of shortening and the dynamic constants of muscle.
Proc R Soc London Ser B. 1938;126:136–195.
45. Woledge RC, Curtin NA, Homsher E. Energetic Aspects of Muscle
Contraction. London: Academic Press; 1985.
Received August 6, 2002
Accepted September 10, 2002
Decision Editor: James R. Smith, PhD

